Mechanisms outpacing medicine in autoinflammatory diseases.

Abstract excerpt

Autoinflammatory diseases are increasingly defined at the genetic and pathway levels, yet therapeutic predictability has not advanced in parallel. This disconnect is especially evident in monogenic disorders, in which molecular diagnosis can identify the initiating lesion but does not reliably predict the dominant effector process, organ-specific risk, or the treatment most likely to achieve durable control....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Autoimmune Diseases
• Share to Genetic Predisposition to Disease
• Share to Hereditary Autoinflammatory Diseases